logo
London woman becomes first in UK to give birth to baby born from a womb transplant

London woman becomes first in UK to give birth to baby born from a womb transplant

Yahoo08-04-2025
A baby girl has made history as the first child in the UK to be born from a womb transplant. Grace Davidson, 36, from north London, received the organ – also called the uterus – from her older sister, Amy, in the UK's first womb transplant in 2023.
Now, following the huge success of the procedure, she has given birth to baby Amy Isabel, named after her aunt and a surgeon who helped perfect the technique.
The news gives hope to thousands of women born without a womb or whose womb fails to function. Mrs Davidson, an NHS dietitian, and her husband Angus, 37, who works in finance, are over the moon with their new arrival. Baby Amy was born by planned NHS Caesarean section on February 27 at Queen Charlotte's and Chelsea Hospital in London.
READ MORE: 33-year-old given months to live after 'long Covid' turned out to be leukaemia says doctor asked her about Dignitas
READ MORE: Half a million Brits to lose access to free dental work or prescriptions 'within days'
Mrs Davidson said she felt 'shock' when she first held her daughter, adding: 'We have been given the greatest gift we could ever have asked for.' She told the PA news agency: 'It was just hard to believe she was real. I knew she was ours, but it's just hard to believe . Our family are just so happy for us. It sort of feels like there's a completeness now where there maybe wasn't before.'
Mrs Davidson was born with Mayer-Rokitansky-Kuster-Hauser (MRKH), a rare condition that affects around one in every 5,000 women, meaning they have an underdeveloped or missing womb.
However, the ovaries are intact and still function to produce eggs and female hormones, making conceiving via fertility treatment a possibility.
Before receiving the donated womb, Mrs Davidson and her husband underwent fertility treatment to create seven embryos, which were frozen for IVF in central London.
Mrs Davidson then had surgery in February 2023 to receive the womb from her sister Amy Purdie, 42, a former primary school teacher, who is mother to two girls aged 10 and six.
Several months later, one of the stored embryos was transferred via IVF to Mrs Davidson. Amy, who weighed 4.5lb, was delivered several weeks early in the planned 90-minute Caesarean section, to ensure a safe, hospital-based delivery.
Mrs Davidson and her baby stayed in hospital for about a week to establish breastfeeding.
The new mother said: 'The first couple of weeks were tricky because she was so sleepy, and we were struggling to kind of keep her awake enough for her feed, but she's doing really well.
'She had a bit of jaundice to start with, and she needed a bit of light therapy, but she's a stronger feeder now, and she's more alert. She will kind of wake herself up when she wants a feed, which is nice.'
Mr Davidson said the moment his daughter arrived was very emotional.
'She came out crying, and we were a bit worried she would be whisked off to an antenatal ward, but she's been with us every minute of her life so we're so grateful for that,' he said. 'It had been such a long wait. We'd been intending to have a family somehow since we were married, and we've kind of been on this journey for such a long time.
'Having waited such a long time, it's kind of odd getting your head around that this is the moment where you are going to meet your daughter. The room was full of people who have helped us on the journey to actually having Amy.
'We had been kind of suppressing emotion, probably for 10 years, and you don't know how that's going to come out – ugly crying it turns out! The room was just so full of love and joy and all these people that had a vested interest in Amy for incredible medical and science reasons.
'But the lines between that and the love for our family and for Amy are very much blurred – it felt like a room full of love. The moment we saw her was incredible, and both of us just broke down in emotional tears – it's hard to describe, it was elation.'
Mrs Davidson said the couple always had 'a quiet hope' the womb transplant would be a success.
'It was quite a long run up to the transplant, maybe eight years or so, and we kept thinking it might get ruled out for various reasons,' she said.
'But once we had the transplant, I think we were hopeful that things were going to work out. But it wasn't really until she arrived that the reality of it sunk in.'
She added: 'Lots of womb transplants fail in the first two weeks so even just to get to that point was amazing, and having my first period was really amazing, because it showed it was working.
'What helped us through the tough times was sort of thinking this is all going to be worth it… I'm so grateful, it's given us so much.'
She said the couple 'definitely' wanted to have another child. Mrs Purdie, who lives in Scotland, was not at the birth but was only a phone call away.
She said: 'Watching Grace and Angus become parents has been an absolute joy and worth every moment.'
Mrs Purdie said she did not hesitate to think about donating her womb to her younger sister once the living donor transplant programme became a possibility.
'It was very natural,' Mrs Purdie told PA. 'Because we had followed Grace on the plan of a deceased donor, we had gone on the journey with her.
'And then when she mentioned that there was this opportunity, immediately both me and my older sister, Laura, and our mum – we all said we would do it. There was no question about it.'
Mrs Davidson was diagnosed as having no womb when she was 19 and found out about womb transplants at the same time.
'It was very much at the research stages, but the consultant said this might be available in my lifetime,' she said.
'The year before we got married, I just sort of Googled it and found out there was a research team, and there was an email address, so I emailed them.
'We basically got recruited from 800 women down to 10, I think, and that was purely for the deceased donor trial.
'We were on that for maybe three years, and then the living donors really took off as a possibility.
'The team suggested to me that we might want to consider that. I think they thought we'd probably have a family sooner if we went down that road.'
Asked how having a diagnosis of MRKH has affected her life, Mrs Davidson said: 'I think it's hard to know at the time of diagnosis, it's hard to know how it's going to affect you.
'I probably already knew that I wanted to be a mum. There was never any question, and so it was just devastating, to be honest…I sort of just felt a huge sadness over me.'
She said some situations would be upsetting, adding: 'I used to just get triggered by seeing a mum with a pushchair, it's really ordinary stuff and it would kind of catch you by surprise.'
Mrs Davidson said she hopes women in a similar situation will now have more options going forward.
'Like here's this wonderful baby, and there's that real desire in me, like an innate desire, to be a mum, to carry my baby and to know them from the earliest moment.
'So, I think just knowing that that is an option… this is huge, when it wasn't there before.'
During her pregnancy, Mrs Davidson took immunosuppressants to ensure her body did not reject the womb.
She said it was an easy pregnancy, adding: 'I was pretty lucky, I didn't really have much nausea at all.
'I had a bit of bleeding early on, which was a concern, but actually it sort of self-resolved at about 14 weeks. And I was getting regular scans every two weeks. I felt like I had energy right up to the point I delivered. I was still very active and I loved the third trimester because you've got a bump, you can feel them kicking all the time. It was lovely.'
The lead surgeons for the womb transplant were Professor Richard Smith, clinical lead at the charity Womb Transplant UK and consultant gynaecological surgeon at Imperial College Healthcare NHS Trust, and Isabel Quiroga, consultant surgeon at the Oxford Transplant Centre, part of Oxford University Hospitals.
Both surgeons were in the operating theatre when Amy was delivered, and her parents chose her middle name in honour of Miss Quiroga.
Prof Smith, who led the development of womb transplants in the UK, shed tears at the birth. He said: 'I feel great joy actually, unbelievable – 25 years down the line from starting this research, we finally have a baby, little Amy Isabel. Astonishing, really astonishing.'
Miss Quiroga said: 'For me, it's total joy, delight. I couldn't be happier for Angus and Grace, what a wonderful couple.
'It was overwhelming actually, it remains overwhelming. It's fantastic.'
Womb Transplant UK has carried out four womb transplants in the UK – the first on Mrs Davidson and then three on women who received wombs from deceased donors. It has enough cash for two further operations and is fundraising to carry out more.
Kate Brintworth, England's chief midwifery officer, praised the NHS' role in the delivery, adding : 'I am so delighted that Grace, Angus and their whole family have been able to welcome the miracle of Amy to the world.'
Mrs Davidson said she felt 'shock' when she first held her daughter, adding: 'We have been given the greatest gift we could ever have asked for.'
She told the PA news agency: 'It was just hard to believe she was real. I knew she was ours, but it's just hard to believe… Our family are just so happy for us. It sort of feels like there's a completeness now where there maybe wasn't before.'
Mrs Davidson was born with Mayer-Rokitansky-Kuster-Hauser (MRKH), a rare condition that affects around one in every 5,000 women, meaning they have an underdeveloped or missing womb. However, the ovaries are intact and still function to produce eggs and female hormones, making conceiving via fertility treatment a possibility.
Before receiving the donated womb, Mrs Davidson and her husband underwent fertility treatment to create seven embryos, which were frozen for IVF in central London.
Kate Brintworth, England's chief midwifery officer, praised the NHS' role in the delivery, adding: 'I am so delighted that Grace, Angus and their whole family have been able to welcome the miracle of Amy to the world.'
Looking for more from MyLondon? Subscribe to our daily newsletters here for the latest and greatest updates from across London.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

First new treatment for advanced bladder cancer in decades given green light
First new treatment for advanced bladder cancer in decades given green light

Yahoo

timean hour ago

  • Yahoo

First new treatment for advanced bladder cancer in decades given green light

A new treatment for advanced bladder cancer which doubles survival time has been given the green light for NHS use. Experts said the approval of the new treatment combination would bring a 'fundamental shift' in care for patients with late-stage disease, saying that until now, the treatment for advanced bladder cancer had not significantly changed since the 1980s. They said there had been real 'unmet need' for patients with advanced disease, with some 29% of people diagnosed with stage 4 cancer – when the cancer has spread to other parts of the body – surviving for a year after diagnosis. It is estimated that 1,250 people a year could benefit from the treatment. The new treatment combination includes enfortumab vedotin, an antibody-drug which is also known as Padcev, made by Astellas and Pfizer – with pembrolizumab, a drug known as a PD-L1 inhibitor, also known as Keytruda, which is made by Merck. Clinical trials suggest that the treatment combination, when tested against platinum-based chemotherapy, led to improved survival for patients. 'Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since the 1980s,' Professor Thomas Powles, director of Barts Cancer Institute Biomedical Research Centre (QMUL), UK and primary investigator on the trial, said. 'This guidance will fundamentally reshape first-line treatment for eligible patients.' Trial data indicated that patients who took the treatment combination survived for an average of 33.8 months compared to 15.9 months with chemotherapy. Researchers also measured the amount of time people survived without their disease worsening – also known as progression-free survival – and found that people on the combination treatment had just more than a year of progression-free survival compared to half-a-year for those on standard treatment. Three in 10 (30%) patients had a so-called 'complete response' when getting the combination treatment – meaning there was no evidence of cancer remaining. This was compared to 14.5% of those who received chemotherapy. One patient said that taking part in the trial had given him more time with his grandson. Martyn Hewett, 75, from Stratford, east London, received the combination treatment on a trial at Barts Health NHS Trust after surgery to remove his tumours failed. He said: 'I feel very, very lucky, because if I hadn't been on this trial, I imagine I would be dead by now. 'Immediately after the operation that failed, I asked the doctor what the prognosis was, and he said, most people in your position live for a year, and now, three-and-a-half years later here I am. 'I am going to have an extra few years to see my grandson grow up – and maybe even be around to see him get married.' The treatment combination will now be available for NHS patients in England following the approval from the National Institute for Health and Care Excellence (Nice) for patients with 'unresectable or metastatic urothelial cancer for people who are eligible for platinum-containing chemotherapy' and is given as an IV infusion in hospitals or clinics. Dr Timir Patel, medical director of Astellas UK, said: 'The guidance from Nice is excellent news for patients. 'Advanced bladder cancer is in an area where there is a real unmet need. 'This combination therapy changes the standard of care for doctors and their patients.' Helen Knight, director of medicines evaluation at Nice, said: 'This is a highly promising and effective new drug, with clinical trial results highlighting the tremendous difference it could make to the length and quality of people's lives. 'Advanced bladder cancer is a devastating condition which can have a substantial impact on people's daily lives, often leading to them struggling to work, travel or maintain physical activity.' Professor Peter Johnson, NHS England's national clinical director for cancer, said: 'This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a treatment that can almost double their chances of survival, helping thousands to live longer and giving them more precious moments with their loved ones. 'Bladder cancer is often difficult to treat once it has spread, but this new therapy is the first one in years to really help stop the disease in its tracks, and our rollout to NHS patients will make a huge difference to the lives of those affected and their families.' Jeannie Rigby, chief executive of charity Action Bladder Cancer UK, said: 'This new drug has the potential to increase how long people have before their cancer gets worse and how long they live compared with the current, limited, treatment choices available.' Around 18,000 people in England are diagnosed with bladder cancer each year.

Blood matching test to be offered to patients with rare conditions
Blood matching test to be offered to patients with rare conditions

Yahoo

time2 hours ago

  • Yahoo

Blood matching test to be offered to patients with rare conditions

The health service has launched a personalised 'blood matching' test for people with rare conditions who require regular blood transfusions. The move will allow donor blood to be matched to these patients more closely, to reduce the risk of severe reactions. The new test uses genetics to generate detailed blood group information. It is the first time it has been used for patients with rare inherited anaemias – with around 300 people eligible for testing, according to NHS Blood and Transplant (NHSBT). The programme has been backed by the family of toddler Woody Mayers, aged 22 months, who has a rare inherited anaemia called congenital dyserythropoietic anaemia (CDA) type 1. The condition causes the bone marrow to struggle to produce healthy red blood cells, which carry oxygen around the body. It is estimated to affect between one to five out of every million babies. Patients have low haemoglobin levels, meaning Woody relies on blood transfusions every four weeks to stay alive. However, the donor blood must be carefully matched to reduce the risk of patient's developing antibodies against certain blood types, which can cause severe reactions and make transfusions more difficult in the future. The new genotyping testing programme, a partnership between NHSBT and NHS England, uses genetics to identify more of the rarer blood groups. Samples are collected at routine hospital appointments, with patients' DNA tested to find out their blood types. About 300 people with transfusion dependent, rare inherited anaemias, are eligible for the test. All patients with sickle cell disorder and thalassaemia are also eligible, even if they do not rely on blood transfusions. Kate Downes, head of genomics at NHSBT, said: 'The new genotyping test can test blood groups faster and more extensively than standard testing methods.' Professor Dame Sue Hill, chief scientific officer at NHS England, said: 'The power of genomics is transforming medicine, with extended blood group genotyping now being utilised to help patients, especially those requiring regular transfusions. 'This is an exceptional example of an evidence-based innovation, developed from genetic data, being used to drive forward improvements that will make a huge difference across the NHS. 'Blood donations can be lifesaving for patients, and the NHS needs a constant flow of donations to provide people with the best possible care, so I'd encourage anyone who can donate to do so.' Woody's family were alerted to potential health conditions at a 20-week pregnancy scan. He was born prematurely at 34 weeks with haemoglobin levels around a quarter of what they should have been. Woody's mother Polly Mayers, 35, from Robertsbridge in East Sussex, said: 'When he was born, he was very poorly and pale. He didn't cry for a few minutes. He needed ventilation breaths. It was really frightening. 'The first few days were very critical for Woody. He was extremely unwell. Nobody knew the cause for his haemolytic anaemia.' The toddler has now being having regular transfusions fore more than a year, receiving 140mls of red blood cells every four weeks to boost his haemoglobin. Despite this, his family describes him as an energetic little boys who likes trips to the park and riding his bike. His mother added: 'Woody will need the blood to be well-matched so that his transfusions don't become too difficult or risky. 'The test will help him and anyone else with a similar condition. I hope everyone eligible gets it.' Ms Downes said: 'Woody has very rare disorder and he relies on blood transfusions to stay alive but these need to be well matched. 'We want everyone eligible, like Woody, to be tested so they can get better matched blood. We also need more people to donate, so we can supply the matched lifesaving blood to Woody and people like him.' Woody's family are also urging people to donate blood. Mrs Mayers, a community matron, said: 'There's no way to sugar-coat it – if it wasn't for blood donors, Woody would not be alive. 'I'm incredibly grateful to blood donors for ensuring blood is available when he needs it.'

NHS says eight services need to be paid for with millions warned
NHS says eight services need to be paid for with millions warned

Yahoo

time4 hours ago

  • Yahoo

NHS says eight services need to be paid for with millions warned

The NHS has warned eight things UK households may have to pay for with millions warned. The NHS says although most NHS treatment is free, there is usually a charge for eight items. This includes NHS prescriptions, NHS dental check-ups and treatment and sight tests as well as new glasses or contact lenses, repairing or replacing glasses or contact lenses, NHS wigs and NHS fabric supports – things like surgical bras, support tights and spinal supports. The list is completed by travel for NHS treatment. The NHS advises: "You could be entitled to help with these costs depending on your circumstances. It should take about 3 minutes to check." READ MORE: Lloyds Bank announces start date of new £300 rule with customers warned READ MORE: Pub-goers in England face 'insidious' and 'stealth' new rule at the bar READ MORE Hobbycraft shutting 9 of 115 stores with full list announced The health body adds: "We use your date of birth to work out your age. Depending on where you live, your age could entitle you to help with NHS costs, such as free prescriptions or dental treatment." Speaking previously over NHS prescription charges being frozen, Labour Party MP Secretary of State for Health and Social Care, Wes Streeting, said: "This government's Plan for Change will always put working people first, and our moves today to freeze prescription charges will put money back into the pockets of millions of patients. "Fixing our NHS will be a long road - but by working closer with our pharmacies we're saving money and shifting care to the community where it's closer to your home. "We made the difficult but necessary choices at the budget to fund moves like this and change our NHS so it can once again be there for you when you need it." Around 89% of prescriptions in England are already dispensed free of charge to children, the over 60s, pregnant women and those with certain medical conditions. This freeze will not impact that scheme. In addition to the freeze on charges, the NHS Low Income Scheme offers help with prescription payments, with free prescriptions for eligible people in certain groups such as pensioners, students and those who receive state benefits or live in care homes.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store